0.25
+0.0045(+1.80%)
Currency In USD
| Previous Close | 0.25 |
| Open | 0.25 |
| Day High | 0.26 |
| Day Low | 0.23 |
| 52-Week High | 1.69 |
| 52-Week Low | 0.23 |
| Volume | 661,985 |
| Average Volume | 901,252 |
| Market Cap | 51.37M |
| PE | -1.42 |
| EPS | -0.18 |
| Moving Average 50 Days | 0.36 |
| Moving Average 200 Days | 0.79 |
| Change | 0 |
If you invested $1000 in Tevogen Bio Holdings Inc. (TVGN) since IPO date, it would be worth $25.64 as of February 11, 2026 at a share price of $0.255. Whereas If you bought $1000 worth of Tevogen Bio Holdings Inc. (TVGN) shares 3 years ago, it would be worth $24.05 as of February 11, 2026 at a share price of $0.255.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
GlobeNewswire Inc.
Jan 30, 2026 8:00 PM GMT
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders WARREN, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
GlobeNewswire Inc.
Jan 29, 2026 7:45 PM GMT
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue WARREN, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE)
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
GlobeNewswire Inc.
Jan 12, 2026 2:00 PM GMT
Jan. 12, 2026, San Francisco. Issued from the J.P. Morgan Healthcare Conference WARREN, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today reported significant scientific and operational